Dorothy Morgan, 47, of Hempstead
The identity of two previously unidentified victims of the 9/11 Word Trade Center attacks were confirmed just days before the U.S. marks the 20th anniversary of the tragedy.
The New York City Chief Medical Examiner's Office said Dorothy Morgan, of Hempstead, and a man whose family asked that his name to be with held, were identified through ongoing DNA testing of the 1,108 victims who could not be identified.
'Twenty years ago, we made a promise to the families of World Trade Center victims to do whatever it takes for as long as it takes to identify their loved ones, and with these two new identifications, we continue to fulfill that sacred obligation,' said Dr. Barbara A. Sampson, Chief Medical Examiner of the City of New York.
'No matter how much time passes since September 11, 2001, we will never forget, and we pledge to use all the tools at our disposal to make sure all those who were lost can be reunited with their families.'
Morgan, 47, who worked as a broker in Marsh & McLennan at the World Trade Center, was identified through testing remains recovered in 2001.
The unnamed man's identity was confirmed through testing remains recovered in 2001, 2002, and 2006.
Dorothy Morgan and the unnamed man were among the 2,754 people who died at the World Trade Center during the terrorist attack on September 11, 2001
'No matter how much time passes since September 11, 2001, we will never forget,' said Barbara Sampson, New York City's Chief Medical Examiner
Of the 2,753 victims of the September 11 attacks, the remains of 1,646 have been identified - Michael Haub, a member of FDNY's Ladder Company 4, was identified in 2019
They are the first two victims to be identified since Michael Haub in October 2019, but about 40 per cent of the estimated 2,753 who died at the World Trade Center remain unidentified, ABC 7 reported.
Mark Desire, head of the Office of Chief Medical Examiner's missing persons and body identification unit, said the two were identified through a new breakthrough technique call Next-Generation Sequencing.
NGS uses a device about the size of a desktop printer, which analyzes different components of DNA than longer-standing methods - instead of using the nucleus of a cell the machine looks at genetic materials found in mitochondria.
While experts have said that some of the remains have been rendered unidentifiable by the damage they're incurred, the
